SANDOSTATIN LAR 30 MG
OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG · DIN 02239325 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: MARKETED
What is SANDOSTATIN LAR?
SANDOSTATIN LAR 30 MG contains OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02239325, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as Powder For Suspension, Sustained-Release for Intramuscular administration. Health Canada currently lists it as marketed, status dated 27-Jan-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239325 |
|---|---|
| Brand name | SANDOSTATIN LAR |
| Generic / active ingredient | OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 30 MG |
| Dosage form | Powder For Suspension, Sustained-Release |
| Route of administration | Intramuscular |
| Schedule | PRESCRIPTION |
| ATC code | H01CB02 OCTREOTIDE |
| AHFS class | 92:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Jan-1999 |
| Original market date | 1999-01-27 00:00:00 |
Is OCTREOTIDE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code H01CB02 OCTREOTIDE. 9 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| OCTREOTIDE ACETATE OMEGA | 100 MCG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02248640 |
| OCTREOTIDE ACETATE OMEGA | 200 MCG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02248642 |
| OCTREOTIDE ACETATE OMEGA | 50 MCG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02248639 |
| OCTREOTIDE ACETATE OMEGA | 500 MCG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02248641 |
| OCTREOTIDE INJECTION | 100 MCG | SOLUTION | STERIMAX INC | MARKETED | DIN 02560240 |
| OCTREOTIDE INJECTION | 200 MCG | SOLUTION | STERIMAX INC | MARKETED | DIN 02560283 |
| OCTREOTIDE INJECTION | 500 MCG | SOLUTION | STERIMAX INC | MARKETED | DIN 02560291 |
| SANDOSTATIN | 50 MCG | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 00839191 |
| OCPHYL | 100 MCG | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02413205 |
| OCPHYL | 50 MCG | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02413191 |
Who else supplies OCTREOTIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OCTREOTIDE appears in 173 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.